NCT07265674
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07265674
Title A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer (Beacon-BTC)
Acronym Beacon-BTC
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors J-Pharma Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center (Site 106) Gilbert Arizona 85234 United States Details
City of Hope (Site 107) Duarte California 91010 United States Details
University of California at Irvine (Site 101) Orange California 92868 United States Details
UCLA Medical Center (Site 117) Santa Monica California 90404 United States Details
Norton Cancer Institute (Site 115) Louisville Kentucky 40127 United States Details
Ochsner Medical Center (Site 120) New Orleans Louisiana 70121 United States Details
Henry Ford Cancer Center (Site 113) Detroit Michigan 48186 United States Details
Karmanos Cancer Center (Site 109) Detroit Michigan 48201 United States Details
Masonic Cancer Center, University of Minnesota (Site 116) Minneapolis Minnesota 55455 United States Details
Rutgers Cancer Institute of New Jersey (Site 103) New Brunswick New Jersey 08901 United States Details
Rosewell Park Comprehensive Cancer Center (Site 114) Buffalo New York 14263 United States Details
Memorial Sloan Kettering Cancer Center (Site 108) New York New York 10065 United States Details
University Hospitals Cleveland Medical Center Seidman Cancer Center (Site 111) Cleveland Ohio 44106 United States Details
James Cancer Hospital and Solove Research Institute (Site 119) Columbus Ohio 43219 United States Details
Mercy Clinic (Site 110) Oklahoma City Oklahoma 73120 United States Details
Allegheny Health Network (Site 121) Pittsburgh Pennsylvania 15212 United States Details
University of Texas Southwestern Medical Center (Site 104) Dallas Texas 75390 United States Details
University of Texas MD Anderson Cancer Center (Site 102) Hosuton Texas 77030 United States Details
Houston Methodist (Site 118) Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field